Variant report
Variant | esv2021602 |
---|---|
Chromosome Location | chr5:15906355-15912876 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181480349 | chr5:15906367-15906368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560629991 | chr5:15906373-15906374 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572604624 | chr5:15906407-15906408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546152884 | chr5:15906408-15906409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs186065303 | chr5:15906433-15906434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531593550 | chr5:15906455-15906456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189647064 | chr5:15906458-15906459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549790540 | chr5:15906463-15906464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561843793 | chr5:15906494-15906495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529386294 | chr5:15906514-15906515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144925076 | chr5:15906525-15906526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78411276 | chr5:15906528-15906529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74431391 | chr5:15906545-15906546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs71605516 | chr5:15906546-15906547 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs397996858 | chr5:15906564-15906565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370444716 | chr5:15906616-15906617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565688358 | chr5:15906622-15906623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34465454 | chr5:15906623-15906624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs7734198 | chr5:15906624-15906625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs397882220 | chr5:15906637-15906638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371471161 | chr5:15906679-15906680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs373746393 | chr5:15906693-15906694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs151298909 | chr5:15906697-15906698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551349539 | chr5:15906714-15906715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111915692 | chr5:15907122-15907123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113435044 | chr5:15907125-15907126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112645040 | chr5:15907342-15907343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112396842 | chr5:15907588-15907589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201611638 | chr5:15908634-15908635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs199979087 | chr5:15909613-15909614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs199751452 | chr5:15910215-15910216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367580187 | chr5:15911357-15911358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs200597338 | chr5:15911419-15911420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569965350 | chr5:15911620-15911621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs537043236 | chr5:15911621-15911622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs372268175 | chr5:15911641-15911642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376657014 | chr5:15911797-15911798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs368436576 | chr5:15911831-15911832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs6894115 | chr5:15911894-15911895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs201349221 | chr5:15912143-15912144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561271857 | chr5:15912223-15912224 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555445360 | chr5:15912267-15912268 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567282014 | chr5:15912282-15912283 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs534659273 | chr5:15912283-15912284 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372381604 | chr5:15912308-15912309 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370966858 | chr5:15912343-15912344 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs572513574 | chr5:15912355-15912356 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546412294 | chr5:15912373-15912374 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558144875 | chr5:15912376-15912377 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs375213185 | chr5:15912390-15912391 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 21364760 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:15900200-15915400 | Weak transcription | Small Intestine | intestine |
2 | chr5:15904400-15906400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr5:15904600-15913000 | Weak transcription | Fetal Stomach | stomach |
4 | chr5:15906200-15906400 | Enhancers | NHLF | lung |
5 | chr5:15912200-15912600 | Active TSS | HUES64 Cell Line | embryonic stem cell |
6 | chr5:15912200-15912800 | Active TSS | H1 Cell Line | embryonic stem cell |
7 | chr5:15912400-15912600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr5:15912400-15912800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
9 | chr5:15912400-15912800 | Active TSS | HUES6 Cell Line | embryonic stem cell |
10 | chr5:15912600-15913000 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
11 | chr5:15912600-15913000 | Flanking Active TSS | iPS-15b Cell Line | embryonic stem cell |
12 | chr5:15912600-15913200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
13 | chr5:15912600-15914000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr5:15912800-15913000 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
15 | chr5:15912800-15913000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
16 | chr5:15912800-15913200 | Enhancers | H1 Cell Line | embryonic stem cell |
17 | chr5:15912800-15913200 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
18 | chr5:15912800-15913400 | Enhancers | Fetal Lung | lung |
19 | chr5:15912800-15913800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |